Remedium Bio - About the company
Remedium Bio is a seed company based in Needham (United States), founded in 2020 by Frank Luppino. It operates as a Developer of gene therapies for a broad range of diseases. Remedium Bio has raised $3.5M in funding from LifeSpan Vision Ventures. The company has 1121 active competitors, including 397 funded and 256 that have exited. Its top competitors include companies like Moderna, BridgeBio and Spark Therapeutics.
Company Details
Developer of gene therapies for a broad range of diseases. The company is developing a pipeline of a broad range of therapies for immune and age-related conditions which includes RMD 1101 for rheumatology, RMD 1202 for endocrinology, RMD 1501 for neurology, and RMD 1201 for Type-1 diabetes.
- Website
- remedium-bio.com
- Social
- Email ID
- *****@remedium-bio.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2020
Location
Needham, United States
Stage
Seed
Total Funding
$3.5M in 5 rounds
Latest Funding Round
Investors
Ranked
218th among 1121 active competitors
Sign up to download Remedium Bio's company profile
Remedium Bio's funding and investors
Remedium Bio has raised a total funding of $3.5M over 5 rounds. Its first funding round was on Apr 16, 2021. Its latest funding round was a Seed round on Sep 10, 2024 for $*****. 1 investor participated in its latest round. Remedium Bio has 10 institutional investors.
Here is the list of recent funding rounds of Remedium Bio:
Filter this list
Filter this listDate of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 10, 2024 | 7749261 | Seed | 7114134 | 2573004 | 1560303 | 9964472 |
Aug 01, 2023 | 8626055 | Grant (prize money) | 4506242 | 9259190 | 6664372 | |
Aug 16, 2022 | 3664009 | Seed | 9952664 | 2509441 | 6420345 |
Access funding benchmarks and valuations. Sign up today!View details of Remedium Bio's funding rounds and investors
Remedium Bio's founders and board of directors
Founder? Claim ProfileThe founders of Remedium Bio is Frank Luppino. Frank Luppino is the CEO of Remedium Bio.
Here are the details of Remedium Bio's key team members:
- Frank Luppino: Founder & CEO of Remedium Bio.
View details of Remedium Bio's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Remedium Bio's Competitors and alternates
Top competitors of Remedium Bio include Moderna, BridgeBio and Spark Therapeutics. Here is the list of Top 10 competitors of Remedium Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 81/100 | |
2nd |  BridgeBio 2015, Palo Alto (United States), Acquired | Developer of therapeutics for the treatment of genetic diseases | $434M | 75/100 | |
3rd |  Spark Therapeutics 2013, Philadelphia (United States), Acquired | Developer of gene therapy for rare diseases | $82.8M | 75/100 | |
4th | Developer of antibody-based drugs to treat autoimmune diseases and cancer | $61.9M | 74/100 | ||
5th |  Exact Sciences 1995, Madison (United States), Public | Provider of non-invasive molecular diagnostic testing solutions for cancer | - | 73/100 | |
6th |  Forge Biologics 2020, Columbus (United States), Acquired | Developer of gene therapeutic solutions for treating multiple diseases | $330M | 72/100 | |
7th |  Fulcrum Therapeutics 2015, Cambridge (United States), Public | Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases | $115M | 72/100 | |
8th |  Strand Therapeutics 2017, Cambridge (United States), Series B | Provider of platform to deliver mRNA therapeutics for multi functional treatments | $256M | 72/100 | |
9th |  Insitro 2018, San Francisco (United States), Series C | Developer of an AI-enabled technology platform for the treatment of infectious disease | $643M | 72/100 | |
10th |  Alnylam 2002, Cambridge (United States), Public | Developer of RNA interference-based therapeutics for multiple disorders | $17M | 71/100 | |
218th |  Remedium Bio 2020, Needham (United States), Seed | Developer of gene therapies for a broad range of diseases | $3.5M | 50/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Remedium Bio's competitors? Click here to see the top ones
Remedium Bio's Investments and acquisitions
Remedium Bio has made no investments or acquisitions yet.
Reports related to Remedium Bio
Here is the latest report on Remedium Bio's sector:
News related to Remedium Bio
Media has covered Remedium Bio for a total of 4 events in the last 1 year, 3 of them have been about partnerships.
•
Remedium Signs Landmark Deal with Eli Lilly for Gene TherapiesBusinessFortNight•Sep 23, 2025•Remedium Bio, Lilly
•
Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetesaccessnewswire.com•Sep 08, 2025•Remedium Bio, Lilly, Lila
•
Incyclix Bio Secures $11.25 Million Series B Extension for INX-315 Clinical TrialBenzinga•Aug 25, 2025•Cape Fear BioCapital, Pharmacosmos, Incyclix Bio, Lilly and 2 others
•
LifeSpan Vision Ventures Invests in Remedium BioCNW•Sep 10, 2024•LifeSpan Vision Ventures, Remedium Bio
•
Remedium and Exothera partner on scale-up of gene therapy for osteoarthritisBioPharma-Reporter•Mar 27, 2023•Remedium Bio, Exothera
•
•
Remedium Bio Closes $2.3M Expanded Seed FundingFinSMEs•Aug 16, 2022•Remedium Bio, Sherwood Ventures, Longevitytech.fund,
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Remedium Bio
Explore our recently published companies
- OUI Medical - Dallas based, 2020 founded, Seed company
- MyuNepal - Kathmandu based, 2020 founded, Unfunded company
- So Fetch - India based, 2019 founded, Unfunded company
- CloudRCM Solutions - Park Ridge based, 2020 founded, Unfunded company
- Blitz Learning - India based, 2016 founded, Unfunded company
- Write IT Solutions - Bengaluru based, 2007 founded, Unfunded company
